close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bausch Health Companies Inc. Common Stock (NY:BHC)

6.820 -0.110 (-1.59%)
Official Closing Price Updated: 7:00 PM EST, Dec 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Bausch Health Companies Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
News headline image
Bausch Health Announces Launch of Private Offering of Senior Secured Notes and Conditional Redemption of Senior Notes
Via ACCESS Newswire
News headline image
Hallador Energy, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Bausch Health Announces Next Steps in Financing Initiative with J.P. Morgan
Via ACCESS Newswire
News headline image
Alibaba, Hasbro, Shake Shack, Bausch Health And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Bausch Health Announces Fourth Quarter and Full-Year 2024 Results
Via ACCESS Newswire
News headline image
Earnings Scheduled For February 19, 2025 ↗
 
Via Benzinga
News headline image
Bausch Health Announces 2025 Salix Gastrointestinal Health Scholars Program
Via ACCESS Newswire
News headline image
Bausch Health Stock Pops After-Hours On Q4 Earnings Beat, Bullish Outlook: Retail Confidence Rises ↗
The company’s Solta segment, which includes medical aesthetics, saw Q4 revenue climb 34% to $138 million, fueled by strong demand in South Korea and China. 
Via Stocktwits
Topics Earnings
News headline image
Bausch Health Shares Climb On Better-Than-Expected Q4 Revenue, Strong Forward Guidance ↗
Bausch Health Companies reported its fourth-quarter results after Wednesday's closing bell. Here's a look at the details from the report: 
Via Benzinga
News headline image
Bausch Health to Participate in the J.P. Morgan Global Leveraged Finance Conference
Via ACCESS Newswire
News headline image
Bausch Health Provides Update on Strategic Alternatives
Via ACCESS Newswire
News headline image
Tesla, Nvidia, GM And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Bausch Health Announces Third Quarter 2024 Results
Via ACCESSWIRE
News headline image
Bausch Health to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025
Via ACCESS Newswire
News headline image
Bausch Health Statement on Selection of XIFAXAN(R) (rifaximin) for Inflation Reduction Act's Medicare Negotiation Program
Via ACCESS Newswire
News headline image
Bausch Health Responds to Rumors of a Potential Sale of Bausch + Lomb
Via ACCESSWIRE
News headline image
Deal Dispatch: Ubisoft In Buyout Talks, Dental Supplier Explores Sale, Beloved Drive-Through Goes Bankrupt ↗
Dental supply maker Patterson Companies Inc announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value. 
Via Benzinga
Topics Supply Chain
News headline image
Bausch Health and Salix in Collaboration with Health Organizations Recognize the Second Annual Opioid-Induced Constipation (OIC) Awareness Day
Via ACCESSWIRE
News headline image
Bausch Health Appoints New Chief Medical Officer and Head of R&D
Via ACCESSWIRE
News headline image
Bausch Health and Salix to Present at the American Association for the Study of Liver Disease (AASLD) the RED-C Phase 3 Study Design for a New Investigational Product Designed to Address Serious Complications of Cirrhosis
Via ACCESSWIRE
News headline image
PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency and Quebec's INESSS
Via ACCESSWIRE
News headline image
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday ↗
 
Via Benzinga
News headline image
ACG Presidential Plenary to Highlight Analysis of Xifaxan(R) (rifaximin) Risk Reduction of Overt Hepatic Encephalopathy (OHE) Recurrence
Via ACCESSWIRE
News headline image
Deal Dispatch: UFC, WWE Parent TKO Takes On Bull Riding; Endeavor Looks To Sell Tennis; Another Car Company Goes Bankrupt ↗
IMG tennis assets are on the auction block. The announcement came after TKO inked a deal with Endeavor for Professional Bull Riders. 
Via Benzinga
News headline image
Deal Dispatch: Altus Power, Motorsport Games Explore Options, True Value Goes Bankrupt, M&A Activity Lags ↗
S&P Global's Joe Mantone puts the latest M&A data in perspective and how deal pros might react post-Election Day. 
Via Benzinga
Topics Bankruptcy Stocks
News headline image
Bausch + Lomb Sale Process Gains Momentum As TPG And Blackstone Join Forces ↗
Private equity giants TPG and Blackstone are pursuing a potential $14 billion buyout of Bausch + Lomb. 
Via Benzinga
News headline image
Bausch Health to Announce Third Quarter 2024 Results on October 30, 2024
Via ACCESSWIRE
News headline image
Bausch Health and Salix Survey Highlights Urgent Need for Improved Understanding of Liver Disease Across Healthcare Provider Disciplines as Prevalence of Cirrhosis Rises
Via ACCESSWIRE
News headline image
Bausch Health: A Buyout Bid Could Be the Ticket to Unlock Value
The potential sale of Bausch + Lomb, Bausch Health's eye care business, could result in a financial gain for the company by reducing its debt burden. 
Via MarketBeat
News headline image
Bausch & Lomb And Edgewise Therapeutics Are Among Top 7 Mid Cap Stock Gainers Last Week (Sept 15-Sept 21): Are The Others In Your Portfolio? ↗
Federal Reserve's rate cut boosted tech, construction, industrial, machinery, and financial sectors. Top-performing mid-cap stocks last week. 
Via Benzinga
Topics Economy
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today